Search results will open in a new window on

Exchange Bulletin

MediPharm Labs Corp. (LABS) To Trade On Toronto Stock Exchange

July 25, 2019

Issuer: MediPharm Labs Corp.("MediPharm")


Common shares (the "Shares")



Number of securities issued and outstanding:


Number of securities reserved for issuance:


Listing category:

Industrial, Non-Exempt Issuer

Trading currency:


Listing and posted for trading date:

July 29, 2019 (at the opening)

Other market(s):

The Shares have been listed on TSX Venture Exchange ("TSXV") since October 4, 2018, under the symbol "LABS". The Shares will be delisted from TSXV on July 29, 2019, upon commencement of trading on Toronto Stock Exchange.

The Shares have also been listed for trading on Frankfurt Stock Exchange under the symbol, "MLZ" and on the OTCQX in the U.S. under the symbol, "MEDIF".

Temporary market maker:

Altacorp Capital Inc.

Security ownership registration:

CDS "book-based system"

Investor relations:

Laura Lepore

Vice President, Investor Relations

Tel: (705)719-7425 ext. 216


Business Corporations Act (Ontario)

Fiscal year end:

December 31

Nature of business:

MediPharm is a specialized, research-driven cannabis extraction business focused on downstream extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm's mission is to become a leader specialized in providing derivative cannabis products and to drive future cannabis product innovation.

Transfer agent and registrar:

TSX Trust Company at its principal office in Toronto.


MediPharm has never paid cash dividends on its Shares and does not anticipate paying any cash dividends for the foreseeable future.



TSX contact:

Chris Birkett, Director, Toronto Stock Exchange